A
Atea Pharmaceuticals, Inc. (AVIR)
NMS – Real Time Price. Currency in USD
5.50
+0.09 (1.66%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
5.50
+0.09 (1.66%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.82 | 6.05 | 10 | |
| Quick ratio | 7.82 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -260K | -416K | -416K | -416K | -416K |
| Operating Income | -131M | -164M | -193M | -181M | -181M |
| Net Income | -116M | -136M | -168M | -158M | -158M |
| EBITDA | -130M | -164M | -193M | -180M | -180M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | -38.75 | 1.0 |
| Next quarter | N/A | -28.41 | 1.0 |
| Current year | N/A | 0.52 | 1.5 |
| Next year | N/A | 28.24 | 5.5 |
| Weighted average score | 2.3 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -6.69 | -7.54 | 30.1 | 5.5 |
| Y/Y | 999 | -33.75 | -42.49 | 7.15 | 4.3 |
| 3y average | 999 | -11.71 | -12.31 | -8.51 | 3.3 |
| 5y average | 703.9 | 195.25 | 26.2 | -39.22 | 7.8 |
| Weighted average score | 5.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $95.7M significantly exceed its total debt $843.0K, ensuring strong financial flexibility
Total current assets $311.0M exceed Total current liabilities $39.8M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$28.2M limits the company's ability to reinvest or pay down debt